Dutta A, Satapathy T, Sahu P. EXPLOITING RECEPTOR NANOCLUSTERS TO BIAS CLATHRIN VS. CAVEOLIN UPTAKE: MOLECULAR DESIGN RULES FOR TARGETED ANTI-CANCER NANOMEDICINES. J. Appl. Pharmco. Toxicol. [Internet]. 2026 Jun. 30 [cited 2026 Oct. 23];2(1):17-49. Available from: https://www.joaptonline.com/index.php/joapt/article/view/40